STUTTGART, Germany, February 7, 2017 /PRNewswire/ --
Haselmeier has not even officially presented its latest innovationand the D-Flex. Just one. has already won an award: The especially flexible disposable pen D-Flex has been given the GOOD DESIGN™ Award. However, the D-Flex stands out in the market primarily thanks to its uniqueness. No comparable product can
(Photo: http://mma.prnewswire.com/media/465591/Haselmeier_D_Flex_Image.jpg )
The D-Flex is the disposable pen for the use with 3 ml cartridges. It closes the gap between fixed-dose pens which only allow a single fixed dose, and variable-dose pens where the dose can be finely adjusted by the patient. The D-Flex can therefore be configured for several fixed doses. These dose values can essentially be freely selected when assembling the pen. The pen system does not permit any in-between amounts aside from the set doses, i.e. the patient cannot select an unintentional dose by mistake. This significantly reduces the risk of any operating error and increases the safety of the patient.
This makes the D-Flex the ideal, flexible platform for adapting to set doses in accordance with the therapy. This platform can be flexibly configured to suit the desired dose values, from the first clinical study to series production, thereby significantly reducing the "time to market" and "CAPEX."
The benefit for patients and the advantages for Haselmeier customers are comprehensive:
Stefan Gaul, Strategic Product Manager at Haselmeier, explains: "In line with the needs of the market, we at Haselmeier were looking for an improved solution for "unconventional" or somewhat more complicated applications. Aspects such as patient safety and convenience of operation and handling were central elements of the process. The idea of designing an extremely flexible, strong platform for our customers was naturally a central aspiration. With the D-Flex we have found the ideal way to put this into practice. And it is all the more gratifying when the product design is explicitly appreciated by outside bodies. But above all, it is a good feeling to know that an innovation is far enough advanced in the development process to ensure that patients can be helped within a few years.
The D-Flex product platform made of high-performance plastic will in future be available in the three colours, red, blue and green.
Details of the award
GOOD DESIGN from Chicago is considered the world's oldest and most prestigious institution for design excellence. In 2016, companies from over 46 countries submitted a total of more than 900 new product designs and artwork to the Chicago Athenaeum Museum. The winners are published on the website, www.chi-athenaeum.org and in the 2016 GOOD DESIGN Yearbook.
Haselmeier had already won the award in 2014 for its Axis-D pen platform and a customer application for Merck based upon it. The GONAL-f® 2.0 Pen from Merck is a pre-filled disposable injector which is used worldwide for fertility treatment.
The GOOD DESIGN™ Award has been presented since 1950.
Haselmeier stands for the development and production of innovative self-injection devices with award-winning designs. The Haselmeier Group primarily works on behalf of pharmaceutical and biotechnology companies to improve the lives of patients by manufacturing pens and auto-injectors that are easy to use and that can be dosed with precision. The family business covers all steps-from design to planning to industrialisation-in the creation of high-quality self-injection systems.
Founded as early as in 1920 in Stuttgart, Haselmeier has long been an established name in the medtech industry, thanks to its proprietary technologies and international award-winning designs. In four years from now, this well-established company shall be able to look back on a 100 year old success story. Spread across eight global locations on three different continents, the Haselmeier Group employs a workforce of about 220 employees. While the Development Department is based in Stuttgart, the Innovation and Product Management is sited in Zurich (Switzerland). Haselmeier products are manufactured in the most modern production facilities in Buchen in Odenwald (Germany), Dnešice (Czech Republic) and Bengaluru (India). The international sales are controlled from Stuttgart and have representations in Lowell, Maryland (USA), Gurgaon (India) and Guangzhou (China).
For further information, please visit: www.haselmeier.com
Media Contact: Wilhelm Haselmeier GmbH & Co. KG Vaihinger Straße 48 70567 Stuttgart Germany Jana Heidrich Marketing and Sales Coordinator +49-711-71978-176 firstname.lastname@example.org
SOURCE Haselmeier AG
Subscribe to our Free Newsletters!
Cardiopulmonary bypass is a technique which allows performing open heart surgical procedures in a ...
Acyclovir is an effective antiviral medication used primarily for treating the symptoms of herpes ...
Fasciotomy is a surgical procedure where the fascia is incised to relieve the compartmental ...View All